《港股開市》恆指高開187點 石藥彈逾6% 百度揚逾4%
內地修訂中概股境外檢查規定,明確會計檔案管理要求,恆指今早高開187點或0.85%,報22,227點;國指高開81點或1.08%,報7,618點;恆生科技指數高開81點或1.81%,報4,606點。
在美上市中概股高開,阿裏巴巴(09988.HK)高開0.8%報110.6元,京東(09618.HK)高開2.6%報235元,百度(09888.HK)高開4.4%報141.2元,網易(09999.HK)高開3.5%報151.7元,嗶哩嗶哩(09626.HK)高開4.7%報223元。理想汽車(02015.HK)及小鵬汽車(09868.HK)各高開4.4%及4%,蔚來(09866.HK)高開3%。
其他科技股亦造好,騰訊(00700.HK)高開2.6%報388.8元,美團(03690.HK)高開3%報160.1元,快手(01024.HK)高開1.9%報74.5元。
金融股方面,匯控(00005.HK)低開0.1%報54.3元,港交所(00388.HK)及友邦(01299.HK)各高開0.5%及0.2%。
比亞迪(01211.HK)三月銷量按年增加1.57倍,股價高開1.5%。石藥(01093.HK)新冠疫苗獲內地批準開展臨牀研究,股價高開6.1%報9.38元。藥明生物(02269.HK)高開2.5%報67.5元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.